Msl 360

Michael T. Cullen, MD, MBA: As an accomplished and experienced Chief Medical Officer, Dr. Cullen’s career spans over 20 years in the biotech and pharmaceutical industry. During this time, he has had responsibility for business development, medical/regulatory affairs and clinical research. Dr. Cullen’s background includes extensive experience in hematology, oncology and oncology supportive care. Throughout his career, Dr. Cullen has authored sections in multiple New Drug Applications (NDAs) and lead negotiations with FDA that resulted in approval of several new products. He received his MD from the University of Minnesota and his MBA from University of St. Thomas, St. Paul, MN. Dr. Cullen specializes in clinical development, regulatory approval and launch support of hematology and oncology products for the pharmaceutical industry.